December 12, 2024: Judge Approves Schedule for Upcoming Motions in Federal Ozempic MDL On December 3, 2024, the federal Judge handling the massive case against the makers of Ozempic entered a scheduling order to set deadlines for the defendants motions to dismiss
"It's a significant decrement in the ability to taste the basic taste qualities." "Altered taste sensation, known medically as dysgeusia, is a well-known class effect for all marketed GLP-1s and has been listed in the respective prescribing information for these medicines," a spokesperson for Novo Nordisk, maker of popular GLP-1s Ozempic, Wegovy and Victoza, told USA TODAY via email
[1] Dulaglutide (Trulicity): 0.75 mg or 1.5 mg once weekly for type 2 diabetes
And this in turn can reduce hyperactivity and impulsive behavior
What is the best day of the week for a GLP-1 shot
DeVries, J